According to No.14 of Chapter 4 of the Measures for the Administration of Private Equity Investment Fund Raising Behavior: “Private fund managers and private equity fund sales institutions may not raise funds from organizations and individuals other than qualified investors, and may not promote to non-specific objects by public communication media such as newspapers, radio stations, televisions, the Internet or through the lectures, presentations, analysis meetings and announcements, flyers, SMS, WeChat, blogs, and e-mails."
Based on the provisions of the Measures for the Administration of Private Equity Investment Fund Raising Behavior, Cornerstone Capital will only promote and recommend relevant private equity fund products to certain qualified investors.
If you are interested in investing in private equity investment funds and meet the requirements as a qualified investor by Measures for the Administration of Private Equity Investment Fund Raising Behavior, you will have the corresponding risk identification capability and risk-taking ability. The amount invested in a single private equity fund is not Less than 1 million yuan, and personal financial assets is not less than 3 million yuan or the average annual income of individuals in the last three years is not less than 500,000 yuan. Please read this tip in detail and register as a specific qualified investor of the Cornerstone Capital to obtain the promotion and service of the private equity investment fund.
Cornerstone Capital focuses on value investing in global emerging economies areas. The investment phase spans the early, middle and late stages. And the invested industry covers TMT, biomedicine, energy conservation, environmental protection and so on. The core members of Cornerstone Capital are from top investment banks at home and abroad, involving a lot of resources to invest in domestic and overseas capital markets for more than 20 years. The leading listed financing, mergers and acquisitions and other projects are about 150 cases. Among them, there are more than 50 companies listed on the stock exchanges in the mainland China, Hong Kong, the United States, and Singapore.
As a leader in the corporate capital market, Cornerstone Capital leverages its strengths to assist companies in resolving capital markets from the Pre-ipo, cornerstone investors, new share subscriptions, private placements, block trades, mergers and acquisitions, and privatization returns. Assist companies to solve various adversities and problems in the capital market.
Exploring the Value, Investing the Future is the constant investment philosophy of Cornerstone Capital. Cornerstone Capital grasps global cyclical investment opportunities, and its products cover domestic and foreign primary and secondary markets, including equity funds, secondary market funds, and commodity futures quantitative funds. On behalf of the product, the Oriental Value Private Fund successfully withdrew from the liquidation in October 2017, and the Oriental Value Private Fund was ranked among the top three private equity yields in 2016.
20Year
Involved a lot of resources to domestic and foreign capital markets for more than 20 years.
150Cases
Leading around 150 cases in listed financing, mergers and acquisitions, etc.
50Companies
More than 50 companies have listed and trading.
Unum Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing new immunotherapeutic products designed to treat cancer using the patient's immune system. It was listed on the NASDAQ Stock Exchange in the United States , code: UMRX.
Aimmune is a clinical-stage biopharmaceutical company that is pursuing a new approach to treatment, including the development of proprietary drug candidates for the treatment of peanuts and other food allergies. It was listed on the NASDAQ Stock Exchange on August 6, 2015, code: AIMT.
Tocagen Inc. specializes in developing first-class, broadly applicable product candidates designed to activate patients' immune systems for their own cancers. It was listed on the NASDAQ Stock Exchange on April 13, 2017, code: TOCA.
Kiniksa Pharmaceuticals, Ltd. was established in Bermuda on July 21, 2015. Kiniksa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, acquisition, development and commercialization of therapeutic drugs for patients with severe unmet medical needs.
Loxo Oncology is a biopharmaceutical company that provides innovative, highly selective drugs for genotyping cancer patients. Listed on the NASDAQ Stock Exchange in the US on 2014-08-01, code: LOXO.
Corcept Therapeutics Incorporated is a pharmaceutical company that conducts research, development and commercial drug treatment for people with severe metabolic and psychiatric conditions. Listed on the NASDAQ Stock Exchange in the United States, code: CORT.
ARMO BioSciences, which focuses on the development of tumor immunomodulatory preparations, was listed on the NASDAQ market on January 26, 2018 under the symbol of "ARMO".
Mogu Street, an e-commerce site dedicated to fashion women consumers, offers girls clothing, shoes, bags, accessories and beauty products for young women. Mogu StreetAPP has become a must-have app for fashion women to buy and share.
Huya Inc. is a live broadcast interactive platform based on game live broadcast. It is mainly based on game live broadcast, covering entertainment, variety, education, outdoor, sports and other live content.
JD Finance operated independently in October 2013 and is positioned as a technology company serving financial institutions. So far, 11 business segments have been established - corporate finance, consumer finance, wealth management, payment, crowdfunding, insurance, securities, rural finance, financial technology, overseas business, and urban computing.
CICC, the full name is China International Capital Corporation, was established on June 25th, 1995. It is the first Sino-foreign joint venture investment bank in Mainland China and was listed on the Main Board of the Hong Kong Stock Exchange on November 9th, 2015. CICC became the largest equity investment bank in China during the restructuring of large-scale state-owned enterprises in China. Coupled with the salary level that can be in the same league as the international investment banks, CICC is known as the "nobility of investment banks."
Guoxin Securities Co., Ltd. is a large-scale comprehensive securities company, AA-class Securities Company with a registered capital of 7 billion yuan, having 54 outlets in 38 cities across the country and currently employs 9,443 people.
CITIC Securities Company Limited (English name: CITIC Securities Company Limited) is the first batch of integrated securities companies that China Securities Regulatory Commission approved, the precursor was CITIC Securities Co., Ltd. CITIC Securities Company Limited was established in Beijing on October 25, 1995 and the registered Capital is 6,630,467,600 yuan.
On November 27, 2018, Cornerstone Capital joined Wuhan University to built a “Global Financial Research Studio”.
In 2017, School of Economics and Trade from South China University of Technology, together with Cornerstone Capital, built "International Financial Research and Practice Base" and "Financial engineering Research Center Practice Base".
May 26, 2017, School of Mathematical Sciences from South China Normal University and Cornerstone Capital jointly to create a "Quantitative Investment Laboratory."
Primary Market
Secondary Market
IPO Cornerstone Investment
Commodity Future
The series of Oriental Value Private Fund is the representative product of Cornerstone Capital and the first privately funded QDII fund in China focusing on Chinese stock investment. At present, the Oriental Value Private Fund and the Oriental Value Private Fund II, which have been liquidated, have achieved cumulative yields of 101.31% and 24.50% respectively, which are highly recognized by the industry.
The Value Regression Series Fund is a private equity fund invested by Cornerstone Capital in a listed company that intends to privatize. It is mainly invested in privatized companies of US stocks, and its targets are distributed in TMT, media communications and other industries.
The Unicorn Series Fund is a private equity QDII fund invested by Cornerstone Capital in a unicorn company. The fund invests mainly in unicorn companies in the industries of e-commerce, culture and entertainment, biomedicine, and cloud computing.
The Quantitative Hedging Series Fund is a private equity fund that Cornerstone Capital issues through its quantitative analysis and computerized programming. The main quantitative methods used by the fund include data mining methods such as machine learning, pattern recognition, and neural networks.
The series of Oriental Value Private Fund is the representative product of Cornerstone Capital and the first privately funded QDII fund in China focusing on Chinese stock investment. At present, the Oriental Value Private Fund and the Oriental Value Private Fund II, which have been liquidated, have achieved cumulative yields of 101.31% and 24.50% respectively, which are highly recognized by the industry.
020-38917643
020-38917643-102
contact@connerstonecapital.com
Room 4901 Pearl River Road 6th Chow Tai Fook Financial Center, Tianhe District, Guangzhou ,Guangdong，China
